Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers
Similar Posts
UnaliWear Secures Strategic Investment from Maxim Ventures
Kanega Watch Supports Independent but Vulnerable Populations UnaliWear™ and Maxim Integrated Products, Inc. today announced the initial closing of…
Conversa and Allscripts® Forge Strategic Partnership To Transform Doctor – Patient Communications
SAN FRANCISCO, July 25, 2017 /PRNewswire/ — As health systems increasingly focus on patient engagement and satisfaction, Conversa and Allscripts…
Propeller Health Receives FDA Clearance for the Propeller Platform in Association with GSK’s Ellipta® Inhaler
Propeller’s 8th FDA clearance adds Ellipta inhaler to Propeller’s market leading digitally-guided therapy platform Propeller Health, the leading digital…
Geisinger Taps EarlySign™ for Range of AI Solutions to Identify Patients at Risk of High-Burden Diseases
Multi-Year Partnership to Apply Lower GI Algorithms as First Step in Improving Patient Outcomes Through Personalized and Population Health…